Disease/Infection News

RSS

Annual COVID-19 vaccine proves to be a wise investment for personal health and pocketbook

Study finds that receiving an annual COVID-19 vaccine is clinically and economically beneficial for individuals, regardless of insurance status, offering savings by reducing the likelihood of infection and its associated costs.

11 Apr 2024

Researchers call for a revamped fungal priority list to combat regional disease burdens

Study critiques the World Health Organization's fungal priority pathogens list for not fully reflecting the global burden of fungal diseases, advocating for a revised list that considers regional disparities and elevates the priority of pathogens like Mucorales and Histoplasma spp. to better align with their impact on public health.

11 Apr 2024

ChatGPT could be an effective tool to help reduce vaccine hesitancy

New research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) suggests that the free-to-use, widely accessible ChatGPT could be an effective tool to help reduce vaccine hesitancy among the general public, as well as providing helpful advice on sexually transmitted infections (STIs) in conjunction with sexual health clinics, by improving knowledge and access to care.

10 Apr 2024

Rethinking the germ theory: A balanced take on microbes and disease outcomes

Review explores the complexities of infectious disease outcomes through a balanced perspective, emphasizing the interplay between pathogenic microbes and host conditions, challenging the traditional germ-disease theory by proposing a more integrated view that considers both pathogen virulence and host immunity's impact on disease manifestation.

10 Apr 2024

Researchers create novel drug that can prevent flu-induced lung injury

Infection with the influenza virus leads to lung injury through inflammation over-activation that causes collateral damage to cells required for breathing.

10 Apr 2024

Human-wildlife interface: Starling movements linked to E. coli carriage

Research unveils how spotless starlings' movements, monitored via GPS, relate to the carriage and potential spread of Escherichia coli (E. coli), emphasizing the significant role of bird movement patterns in transmitting pathogens across different environments.

10 Apr 2024

Unraveling the complex web of rectal infections and the microbiome in MSM

Study delves into the relationships between various sexually transmitted infections, including Neisseria gonorrhoeae, Chlamydia trachomatis, Torquetenovirus, and high-risk HPV, and their effects on the anorectal microbiome among men who have sex with men (MSM), unveiling complex interactions that may influence infection outcomes and treatment strategies.

10 Apr 2024

Oxford University and Brazil partner to advance malaria vaccine development

Professor Sue Ann Costa Clemens CBE, Chair of Global Health at the Department of Paediatrics and Head of Oxford Latam Research Group - a collaboration between Oxford and Brazil, aimed at strengthening our commitment to global health - met with His Excellency Antonio Patriota, Brazilian Ambassador to the UK, to discuss the co-development of a Malaria vaccine and advance public health outcomes in Brazil.

10 Apr 2024

Study reveals unexpected vulnerability of lung immune cells to SARS-CoV-2

The lung-cell type that's most susceptible to infection by SARS-CoV-2, the virus that causes COVID-19, is not the one previously assumed to be most vulnerable.

10 Apr 2024

Sugar abnormalities in the blood may promote biological aging and inflammation in HIV patients

The Wistar Institute's associate professor Mohamed Abdel-Mohsen, Ph.D., along with his team and collaborators, has identified sugar abnormalities in the blood that may promote biological aging and inflammation in people living with HIV (PLWH).

10 Apr 2024

Pioneering study launched to examine how the immune system responds to repeated malaria infections

Scientists at the University of Oxford and the University of Edinburgh have launched a pioneering study that examines how the immune system responds to repeated malaria infections.

10 Apr 2024

Global increase in deaths from viral hepatitis revealed in WHO report

According to the World Health Organization (WHO) 2024 Global Hepatitis Report, the number of lives lost due to viral hepatitis is increasing.

10 Apr 2024

Largest-ever global deployment of cholera rapid diagnostic tests for better disease control

The arrival of rapid diagnostic test (RDT) kits for cholera in Malawi today signals the start of a global programme that will see more than 1.2 million tests distributed to 14 countries at high risk for cholera over the next several months.

10 Apr 2024

COVID-19 survivors face lingering health challenges

UC San Francisco researchers examined COVID-19 patients across the United States who survived some of the longest and most harrowing battles with the virus and found that about two-thirds still had physical, psychiatric, and cognitive problems for up to a year later.

10 Apr 2024

Congress likely to kick the can on covid-era telehealth policies

Nearly two hours into a Capitol Hill hearing focused on rural health, Rep. Brad Wenstrup emphatically told the committee's five witnesses: "Hang with us."

10 Apr 2024

Avian flu's leap to humans: Understanding risks and prevention strategies

Comprehensive report by the EFSA and ECDC delves into the factors that could prompt an avian influenza virus to evolve and potentially spark a pandemic, emphasizing the One Health approach for effective prevention and risk mitigation strategies.

10 Apr 2024

Study reveals inflammation's role in long COVID's lingering effects

Large-scale study found that long COVID patients exhibit sustained inflammation and specific immune responses associated with varying symptoms, highlighting the importance of personalized treatment approaches.

9 Apr 2024

Rogue immune cell found to cause poor antibody responses in chronic viral infections

Australian researchers have discovered a previously unknown rogue immune cell that can cause poor antibody responses in chronic viral infections.

9 Apr 2024

Nirmatrelvir fails to shorten COVID-19 symptoms in latest trial

A study in The New England Journal of Medicine evaluates the combination of nirmatrelvir and ritonavir against COVID-19, finding it does not significantly reduce symptom duration in vaccinated or unvaccinated adult outpatients.

8 Apr 2024

Denmark's pertussis epidemic reveals the power of maternal vaccination

A study published in Eurosurveillance details the 2023 pertussis epidemic in Denmark, emphasizing the age-specific incidence, the role of maternal vaccination in reducing infant hospitalizations, and the impact of vaccination strategies on managing the outbreak.

8 Apr 2024